Categories AlphaGraphs, Earnings, Health Care
Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results
Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today.
Total revenues increased 8% year-over-year to $11.9 billion. Revenues grew 10%, excluding FX.
Net earnings attributable to BMS were $1.21 billion, or $0.60 per share, compared to $1.92 billion, or $0.93 per share, last year. Adjusted EPS decreased 10% to $1.80.
For the full year of 2024, BMY expects total revenues to increase around 5% YoY. Adjusted EPS is expected to be $0.75-0.95.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
